We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Kimberly Weinreich Haynes and Boone LLP

Results 1 to 3 of 3

Biosimilars: draft guidance documents issued by FDA *

USA - February 14 2012
The new abbreviated regulatory approval pathway for “biosimilar” and “interchangeable” types of biologic drug products was implemented in the Biologics Price Competition and Innovation Act of 2009 as part of the Patient Protection and Affordable Care Act of 2010.

Co-authors: Jeffrey A. Wolfson.

Accelerated patent examination plan extended *

USA - June 28 2010
Most patent applicants can now accelerate the examination of a select number of patent applications in exchange for abandoning an equal number of unexamined, pending applications, according to an announcement issued by the US Patent and Trademark Office ("PTO") on June 24, 2010.

PTO seeking rulemaking authority despite rescinding proposed claims and continuation rules *

USA - October 12 2009
The U.S. Patent and Trademark Office (“PTO”) has announced that the director has signed a Final Rule, which has not yet been published, that rescinds the hotly contested proposed claims and continuation rules.

Co-authors: Jeffrey A. Wolfson.